Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
申请人:Genentech, Inc.
公开号:US10988478B1
公开(公告)日:2021-04-27
Compounds of Formula 0, Formula I, and Formula II and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
本文描述了式 0、式 I 和式 II 的化合物以及用作白细胞介素-1 受体相关激酶(IRAK4)抑制剂的方法。
REGULATION OF NITRIC OXIDE RELEASE AND BIOFILM DEVELOPMENT
申请人:UNIVERSITY OF WOLLONGONG
公开号:US20140221331A1
公开(公告)日:2014-08-07
The present invention relates generally to methods and compounds for regulating the release of nitric oxide in the vicinity of biofilm-forming microorganisms to regulate programmed cell death in the microorganisms and thereby promote dispersal of microorganism from biofilms and/or inhibit biofilm formation or development. More particularly, the invention relates to the use of compounds to provide spatial and temporal control over nitric oxide release.